Wall Street Zen Downgrades INmune Bio (NASDAQ:INMB) to Sell
INmune Bio (NASDAQ:INMB – Get Free Report) was downgraded by equities researchers at Wall Street Zen from a “hold” rating to a “sell” rating in a research note issued on Saturday. Separately, Weiss Ratings upgraded INmune Bio from a “sell (e+)” rating to a “sell (d-)” rating in a report on Monday, July 20th. One […]
27 Jul 05:54 · The Markets Daily